GGrantIndex
Sort

30,917 grants matching tumor microenvironment

MDSC Polarization and Helicobacter-induced Gastric Metaplasia

$409,682
Juanita L Merchant · University Of Arizona · R56 · FY2022 · DK

Immunotherapy Strategies for Uveal Melanoma

$409,656
Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma

$409,629
Qing Yi · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA

Adoptive Therapy of Ovarian Cancer with Autologous Genetically Modified T Cells

$409,610
Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA

Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy

$409,560
Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2024 · AG

Project 3: Identifying and targeting mediators of CNS metastasis from lung cancer

$409,557
Don X Nguyen · Yale University · P50 · FY2020 · CA

Statistical methods for genomic analysis of heterogeneous tumors

$409,530
Wenyi Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA

Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation

$409,455
Laura D Attardi · Stanford University · P01 · FY2023 · CA

Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer

$409,428
Kenneth P Olive · Columbia University Health Sciences · R01 · FY2022 · CA

Immunotherapy induced Trm arrest and reverse lung fibrosis

$409,375
Alexander Hillel · Johns Hopkins University · R01 · FY2021 · HL

Immunotherapy induced Trm arrest and reverse lung fibrosis

$409,375
Maureen Renee Horton · Johns Hopkins University · R01 · FY2020 · HL

Induction of Tumor Immunity by Secreted HSP-gp96

$409,374
Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2011 · CA

Microenvironmental Control of Capillary Morphogenesis

$409,292
Andrew J Putnam · University Of Michigan At Ann Arbor · R01 · FY2016 · HL

Surgical Studies on the Role on Gastrin-releasing Peptide in Neuroblastoma

$409,278
Dai H Chung · Vanderbilt University Medical Center · R01 · FY2016 · DK

Surgical Studies on the Role on Gastrin-releasing Peptide in Neuroblastoma

$409,278
Dai H Chung · Vanderbilt University Medical Center · R01 · FY2017 · DK

Developmental Funds

$409,247
Edison Tak-Bun Liu · Jackson Laboratory · P30 · FY2022 · CA

Developmental Funds

$409,247
Edison Tak-Bun Liu · Jackson Laboratory · P30 · FY2020 · CA

Developmental Funds

$409,247
Edison Tak-Bun Liu · Jackson Laboratory · P30 · FY2021 · CA

Developmental Funds

$409,245
Edison Tak-Bun Liu · Jackson Laboratory · P30 · FY2023 · CA

Enhancing anti-PD-1 blockade antitumor efficacy by oncolytic virotherapy-mediated tumor microenvironment immunomodulation

$409,158
Jorge G Gomez-Gutierrez · University Of Missouri-Columbia · R21 · FY2025 · CA

Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death

$409,064
Yoon Yeo · Purdue University · R01 · FY2019 · CA

Integrative framework for surface protein imputation for spatial biology of cancer

$408,829
Hatice Ulku Osmanbeyoglu · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · CA

Develop positive allosteric modulators to enhance XCR1 signaling in cancer

$408,829
Cheng Zhang · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · CA

Immune activation by necroptotic cell death

$408,808
Andrew Atwell Oberst · University Of Washington · R01 · FY2022 · CA

PDK1 as a Novel Target in Melanoma

$408,796
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA